gallamine triethiodide has been researched along with rapacuronium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matko, I; Sato, K; Vizi, ES; Windisch, K | 1 |
| Chetverikov, N; Dolejší, E; Doležal, V; El-Fakahany, EE; Jakubík, J; Kudová, E; Nelic, D; Randáková, A; Szánti-Pintér, E | 1 |
2 other study(ies) available for gallamine triethiodide and rapacuronium
| Article | Year |
|---|---|
Effects of non-depolarizing neuromuscular blocking agents on norepinephrine release from human atrial tissue obtained during cardiac surgery.
Topics: Analysis of Variance; Androstanols; Atropine; Electric Stimulation; Gallamine Triethiodide; Heart Atria; Heart Diseases; Heart Rate; Humans; Myocardium; Neuromuscular Blocking Agents; Neuromuscular Depolarizing Agents; Neuromuscular Nondepolarizing Agents; Norepinephrine; Pancuronium; Pipecuronium; Rocuronium; Tubocurarine; Vecuronium Bromide | 1999 |
Neuroactive steroids, WIN-compounds and cholesterol share a common binding site on muscarinic acetylcholine receptors.
Topics: Allosteric Regulation; Androstanes; Androstenes; Animals; Benzimidazoles; Binding Sites; CHO Cells; Cholesterol; Cricetinae; Cricetulus; Gallamine Triethiodide; Humans; Neuromuscular Nondepolarizing Agents; Neurosteroids; Receptors, Muscarinic; Vecuronium Bromide | 2021 |